Product NDC: | 50419-346 |
Proprietary Name: | Ultravist |
Non Proprietary Name: | iopromide |
Active Ingredient(s): | 768.86 mg/mL & nbsp; iopromide |
Administration Route(s): | INTRA-ARTERIAL |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50419-346 |
Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021425 |
Marketing Category: | NDA |
Start Marketing Date: | 20091230 |
Package NDC: | 50419-346-58 |
Package Description: | 8 BOTTLE in 1 PACKAGE (50419-346-58) > 500 mL in 1 BOTTLE |
NDC Code | 50419-346-58 |
Proprietary Name | Ultravist |
Package Description | 8 BOTTLE in 1 PACKAGE (50419-346-58) > 500 mL in 1 BOTTLE |
Product NDC | 50419-346 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | iopromide |
Dosage Form Name | INJECTION |
Route Name | INTRA-ARTERIAL |
Start Marketing Date | 20091230 |
Marketing Category Name | NDA |
Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
Substance Name | IOPROMIDE |
Strength Number | 768.86 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |